Compounds > scutellarin
Page last updated: 2024-09-05

scutellarin and Fatty Liver, Nonalcoholic

scutellarin has been researched along with Fatty Liver, Nonalcoholic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Ding, X; Guo, J; Hu, S; Jiang, S; Lan, T; Li, H; Luo, D; Piao, S; Rong, X; Tian, S; Wang, L; Wang, W; Weng, Q; Xiao, X; Yang, Y; Yu, Y; Zhang, J; Zhu, Q1
Huang, Y; Huo, Z; Liang, J; Luan, H; Shen, Y; Sheng, L; Wu, F; Zhang, X1
Cheng, J; Fan, H; Kang, Q; Li, Y; Lin, P; Ma, X; Sun, D; Wang, L; Zhao, Z1
Bao, L; Fu, Y; Ji, R; Jin, Y; Ma, X; Peng, J; Sun, H; Wang, C; Zhang, X1

Other Studies

4 other study(ies) available for scutellarin and Fatty Liver, Nonalcoholic

ArticleYear
Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.
    Hepatology (Baltimore, Md.), 2022, Volume: 76, Issue:1

    Topics: Animals; Diet, High-Fat; Flavonoids; Inflammation; Lipid Metabolism; Liver; Liver Cirrhosis; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease

2022
Scutellarin ameliorates hepatic lipid accumulation by enhancing autophagy and suppressing IRE1α/XBP1 pathway.
    Phytotherapy research : PTR, 2022, Volume: 36, Issue:1

    Topics: Animals; Apigenin; Autophagy; Endoribonucleases; Fatty Acids; Glucuronates; Inositol; Lipid Metabolism; Mice; Non-alcoholic Fatty Liver Disease; Protein Serine-Threonine Kinases; X-Box Binding Protein 1

2022
Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Nov-24, Volume: 23

    Topics: Animals; Antioxidants; Apigenin; Diet, High-Fat; Glucuronates; Hyperlipidemias; Lipid Metabolism; Liver; Male; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Triglycerides

2017
Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway.
    Free radical research, 2018, Volume: 52, Issue:2

    Topics: Animals; Antioxidants; Apigenin; Glucuronates; Hep G2 Cells; Humans; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Signal Transduction

2018